Literature DB >> 6166307

In vitro susceptibilities of normal human skin fibroblasts to oncoviruses, and the decreased susceptibility to HSV of fibroblasts from untreated Hodgkin's patients.

P Ebbesen, B F Vestergaard, R Ting, S Haahr, J Genner, A Svejgaard.   

Abstract

Fibroblast cultures established from the skin of 56 healthy controls and 15 untreated Stages I and II Hodgkin's patients (HD) were studied in their 3rd, 4th and 5th in vitro passage with respect to transformation with Simian sarcoma virus (SSV) and SV40 and with respect to replication of herpes simplex virus (HSV) Types 1 and 2, pox virus and interferon release. Susceptibility to the 5 viruses varied independently, except for an inverse correlation between susceptibility to SSV and HSV. HD cultures showed a depressed replication of both types of HSV. There was a borderline (P = 0.02) correlation between magnitude of HSV replication and presence of HL-A type B-w44, but this does not explain the HD control difference. Furthermore, the level of serum antibodies to HSV common antigen was not related to magnitude of in vitro replication. The results thus speak against generally enhanced cellular susceptibility to HSV as a reason for the high titres of serum antibodies to HSV in HD patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6166307      PMCID: PMC2010722          DOI: 10.1038/bjc.1981.125

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  Conditional lethal mutants of vesicular stomatitis virus. I. Phenotypic characterization of single and double mutants exhibiting host restriction and temperature sensitivity.

Authors:  R W Simpson; J F Obijeski
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

2.  Current enigmas in cancer research.

Authors:  L J Old; E A Boyse
Journal:  Harvey Lect       Date:  1973

3.  Case-control study of Hodgkin's disease. II. Herpesvirus group antibody titers and HL-A type.

Authors:  B E Henderson; R Dworsky; H Menck; B Alena; W Henle; G Henle; P Terasaki; G R Newell; W Rawlings; B K Kinnear
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

4.  Occurrence of herpes- and adenovirus antibodies in patients with carcinoma of the cervix uteri. Measurement of antibodies to herpesvirus hominis (types 1 and 2), cytomegalovirus, EB-virus, and adenovirus.

Authors:  B F Vestergaard; A Hornsleth; S N Pedersen
Journal:  Cancer       Date:  1972-07       Impact factor: 6.860

5.  Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease.

Authors:  P H Levine; D V Ablashi; C W Berard; P P Carbone; D E Waggoner; L Malan
Journal:  Cancer       Date:  1971-02       Impact factor: 6.860

6.  C-type virus in tumor tissue of a woolly monkey (Lagothrix spp.) with fibrosarcoma.

Authors:  G H Theilen; D Gould; M Fowler; D L Dungworth
Journal:  J Natl Cancer Inst       Date:  1971-10       Impact factor: 13.506

7.  Establishment of a cell line from an inbred mouse strain for viral transformation studies: simian virus 40 transformation and tumor production.

Authors:  K K Takemoto; R C Ting; H L Ozer; P Fabisch
Journal:  J Natl Cancer Inst       Date:  1968-12       Impact factor: 13.506

8.  Reciprocal patterns of genetic resistance to avian tumor viruses in two lines of chickens.

Authors:  P K Vogt; R Ishizaki
Journal:  Virology       Date:  1965-08       Impact factor: 3.616

9.  Fate of HL-A antigens in aging cultured human diploid cell strains. II. Quantitative absorption studies.

Authors:  C Brautbar; M A Pellegrino; S Ferrone; R A Reisfeld; R Payne; L Hayflick
Journal:  Exp Cell Res       Date:  1973-04       Impact factor: 3.905

10.  The occurrence of virus and interferon in the spleen, serum and brain in mice after experimental infection with West Nile virus.

Authors:  S Haahr
Journal:  Acta Pathol Microbiol Scand       Date:  1968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.